Integrated Endoscopy announced it has begun the international pilot launch of its NUVIS Single-Use Arthroscope technology, a first-of-its-kind endoscope designed for use in arthroscopic surgical procedures in the U.S. The company has received clearance to market the technology from the U.S. Food and Drug Administration (FDA).
NUVIS is a unique battery-operated arthroscope that is designed to provide high definition visualization via a proprietary optical design, while directly addressing key safety and sterility issues associated with traditional, reusable arthroscopes. The single-use nature of the technology provides surgeons with an affordable way to eliminate bio-burden and risk of infection and disease transfer due to lapses in instrument reprocessing; eliminates the need for the traditional light source and the associated heat; and can be used on existing video systems in the marketplace.
As part of this global strategy, Integrated Endoscopy has been working with a number of key hospitals and surgeons around the world, introducing the NUVIS technology. Among the early adopters globally are various centers located in the United Kingdom, France, India, Australia and a number of locations in the U.S.
“We’re excited to be sharing our NUVIS technology with surgery thought leaders around the world,” said Brad Sharp, Integrated Endoscopy’s CEO. “The response has been overwhelmingly enthusiastic, and it’s gratifying to be able to provide the international surgical community a technology we believe will be a superior, less expensive and safer new gold-standard in arthroscopic surgery. With NUVIS, we can provide surgeons with an out-of-the-box, battery-operated, single-use endoscope with high-definition image quality at a price point well below that of reusable scopes. Couple that with our patented, low temperature, embedded LED light source, and we believe we can significantly impact a global market opportunity that exceeds $4 billion.”
Sharp added that Integrated Endoscopy’s NUVIS arthroscope is now available to various select markets around the world, with plans of full global availability by early 2020. With over 16 million arthroscopic procedures worldwide, the NUVIS single-use arthroscope represents a significant opportunity for the company while improving efficiency and safety and reducing costs in operating rooms and surgery centers worldwide.
